T23 is a clinical research site located in Austin, Texas, United States 78759.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
T23 has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Antisynthetase Syndrome.
Sponsors: Cartesian Therapeutics.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Texas · View every site in Austin
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
T23 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
T23 has 1 clinical trials on record, with 1 currently active. Their work covers Antisynthetase Syndrome.
T23 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.